Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 2  (01-2004)

Period of time： 2004年2期

Publisher： Bentham Science Publishers

Founded in： 2001

Total resources： 18

E-ISSN： 1875-5917|4|2

ISSN： 1568-0088

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 2

Menu

Common and Uncommon Features of Rheumatoid Arthritis and Chronic Obstructive Pulmonary Disease: Clues to a Future Therapy

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 2 , Vol. 4, Iss. 2, 2004-06 , pp. 85-92

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Hyperferritinaemia Without Iron Overload: Pathogenic and Therapeutic Implications

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 2 , Vol. 4, Iss. 2, 2004-06 , pp. 93-105

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Regulators of G Protein Signaling: Potential Drug Targets for Controlling Cardiovascular and Immune Function

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 2 , Vol. 4, Iss. 2, 2004-06 , pp. 107-118

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Pathobiology of Osteoarthritis and the Rationale for Using the Chondroitin Sulfate for its Treatment

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 2 , Vol. 4, Iss. 2, 2004-06 , pp. 119-127

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Therapeutic Implications of Immune-endocrine Interactions in the Critically Ill Patients

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 2 , Vol. 4, Iss. 2, 2004-01 , pp. 129-139

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Treatment of Inflammatory and Paraproteinemic Neuropathies

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 2 , Vol. 4, Iss. 2, 2004-06 , pp. 141-148

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Flt3 Ligand Bioactivity and Pharmacology in Neoplasia

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 2 , Vol. 4, Iss. 2, 2004-06 , pp. 149-156

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Activins, Myostatin and Related TGF-&bgr; Family Members as Novel Therapeutic Targets for Endocrine, Metabolic and Immune Disorders

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 4,issue 2 , Vol. 4, Iss. 2, 2004-06 , pp. 157-166

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 8 item(s)